Mode
Text Size
Log in / Sign up
Dr. Julia Lee, PhD
Medical Editor

Dr. Julia Lee, PhD

Oncology, Genomics & Drug Development — Molecular targets, biomarker-stratified trials, accelerated-approval pathways.

Dr. Julia Lee is a freelance medical writer specializing in Oncology, Genomics & Drug Development, with over 10+ years of experience spanning academic research, translational science, and scientific communication. She holds a PhD in Cancer Biology from Stanford University School of Medicine, with additional training in molecular biology, genomics, and translational oncology. She also holds certification in Good Clinical Practice (ICH-GCP) and has completed advanced professional training in medical writing and regulatory communication.

Her research background includes work on tumor microenvironment biology and treatment-related toxicity, with a strong focus on biomarker-driven oncology and precision medicine approaches.

Julia supports biopharmaceutical organizations in developing scientific content for molecularly targeted therapies, biomarker-stratified clinical trials, and drug development programs, including accelerated approval pathways. Her work spans scientific publications, clinical communication materials, and translational research documentation.

Articles in this group — last 14 days

Cardiovascular risk for Janus kinase inhibitors in rheumatoid arthritis remains inconsistent across specific molecules
Drug Pipeline Sys. Review
Cardiovascular risk for Janus kinase inhibitors in rheumatoid arthritis remains inconsistent across specific molecules New data reveals specific risks for some rheumatoid arthritis drugs
This narrative review examines the cardiovascular safety of Janus kinase inhibitors (JAKis) in patients with rheumatoid arthritis and other …
New data shows that one specific rheumatoid arthritis drug carries a higher risk of heart problems for some patients.
Hippo signaling pathway and YAP1 activation contribute to cellular proliferation and progesterone resistance in endometriosis
Drug Pipeline Sys. Review
Hippo signaling pathway and YAP1 activation contribute to cellular proliferation and progesterone resistance in endometriosis Hippo Pathway Activity Linked to Endometriosis Cell Behavior
This narrative review explores the role of the Hippo signaling pathway and YAP1 in endometriosis pathogenesis. The authors suggest these com…
New research identifies the Hippo signaling pathway as a potential non-hormonal target for managing endometriosis and its related cellular b…
Sigma-1 receptor agonists show mechanistic convergence on calcium homeostasis and ER-mitochondria signaling
Drug Pipeline Sys. Review
Sigma-1 receptor agonists show mechanistic convergence on calcium homeostasis and ER-mitochondria signaling New research identifies gaps in treatments for brain cell damage
This scoping review examines sigma-1 receptor (σ1R) agonists, including PRE-084, pridopidine, and SA4503, for neurodegenerative and neuropsy…
Researchers identified specific gaps in how we study and develop drugs to protect brain cells from toxic damage.
Liraglutide may protect against nephrolithiasis in metabolic syndrome via mitochondrial and lipid pathways
Drug Pipeline Sys. Review
Liraglutide may protect against nephrolithiasis in metabolic syndrome via mitochondrial and lipid pathways Liraglutide May Help Prevent Kidney Stones in Metabolic Syndrome
This systematic review synthesizes preclinical and clinical evidence on liraglutide's renal effects in metabolic syndrome, proposing mitocho…
A review suggests liraglutide might protect against kidney stones by calming inflammation and oxidative stress in kidney cells.
Menstrual cycle hormonal fluctuations show weak and variable impacts on athletic performance and injury risk
Drug Pipeline Sys. Review
Menstrual cycle hormonal fluctuations show weak and variable impacts on athletic performance and injury risk Hormonal Fluctuations and Athletic Performance in Female Athletes
This narrative review examines the impact of menstrual cycle hormonal fluctuations on athletic performance and musculoskeletal injury risk i…
New research explores how menstrual cycle hormones affect athletic performance and injury risk, finding that results are highly individual a…
Vietnamese pharmacogenetic variant frequencies differ from East Asian superpopulations in key drug metabolism genes
Drug Pipeline Meta-analysis
Vietnamese pharmacogenetic variant frequencies differ from East Asian superpopulations in key drug metabolism genes Vietnamese Genetic Profiles Differ From General East Asian Data
This systematic review and meta-analysis identifies specific pharmacogenetic variant frequencies within a Vietnamese population compared to …
New data shows that Vietnamese people have unique genetic variations that differ from general East Asian averages for certain medications.
Longan extract and bioactive metabolites may mitigate endothelial damage and regulate blood lipids in vascular diseases
Drug Pipeline Sys. Review
Longan extract and bioactive metabolites may mitigate endothelial damage and regulate blood lipids in vascular diseases Longan extract may help protect blood vessels and manage lipids
This narrative review explores the role of longan extract and its bioactive metabolites in managing vascular diseases. The authors synthesiz…
New research suggests longan fruit extract could protect blood vessels and lower blood sugar in models of vascular disease.
Pharmacological strategies targeting oxidative injury and cell death show potential for intestinal ischemia reperfusion injury
Drug Pipeline Sys. Review
Pharmacological strategies targeting oxidative injury and cell death show potential for intestinal ischemia reperfusion injury New Pharmacological Strategies Show Potential for Intestinal Ischemia Injury
This narrative review explores pharmacological strategies including thiol compounds, polyphenols, and SIRT-axis modulators for managing inte…
New research identifies several compounds and delivery methods that may help protect the gut during intestinal ischemia and reperfusion inju…
Scoping review to map occupational health risks of industrial decarbonization
Drug Pipeline Sys. Review
Scoping review to map occupational health risks of industrial decarbonization New Framework Maps Health Risks of Industrial Decarbonization Processes
This is a scoping review protocol, not a completed study, so no findings are available. It outlines a plan to map evidence on occupational e…
A new research plan aims to identify health risks and safety gaps for workers in industries transitioning to cleaner energy and lower carbon…
Traditional Chinese medicine may modulate neuroimmunomodulatory pathways and immune balance in multiple sclerosis
Drug Pipeline Sys. Review
Traditional Chinese medicine may modulate neuroimmunomodulatory pathways and immune balance in multiple sclerosis Traditional Chinese medicine may influence immune responses in multiple sclerosis
This narrative review examines the mechanisms of traditional Chinese medicine (TCM) preparations in the context of multiple sclerosis. The a…
New research explores how traditional Chinese medicine formulas might balance immune cells and reduce inflammation in people with multiple s…
Honeysuckle therapy improves clinical management of EGFR inhibitor-related skin rash in patients
Drug Pipeline Meta-analysis
Honeysuckle therapy improves clinical management of EGFR inhibitor-related skin rash in patients Honeysuckle Therapy May Help Manage Skin Rashes from EGFR Inhibitors
This meta-analysis of 534 patients evaluated honeysuckle therapy for managing EGFR inhibitor-related skin rash. The analysis found that hone…
Honeysuckle therapy may delay the onset and reduce the severity of skin rashes caused by certain cancer treatments like EGFR inhibitors.
Plasticisers disrupt the hypothalamic-pituitary-thyroid axis and potentially contribute to cardiovascular dysfunction
Drug Pipeline Sys. Review
Plasticisers disrupt the hypothalamic-pituitary-thyroid axis and potentially contribute to cardiovascular dysfunction Plasticisers May Link Thyroid Issues to Heart Health Problems
This narrative review explores how plasticisers, including phthalates and bisphenols, interfere with thyroid hormone synthesis, transport, a…
Common chemicals called plasticisers may disrupt thyroid hormones, which could lead to heart issues like high blood pressure and heart failu…
GPX4-targeted chemical strategies present bidirectional roles and specific translational barriers in multiple disease states
Drug Pipeline Sys. Review
GPX4-targeted chemical strategies present bidirectional roles and specific translational barriers in multiple disease states GPX4 Inhibitors Show Potential for Cancer and Autoimmune Diseases
This systematic review examines the role of GPX4 in cancer, neurodegeneration, ischemia-reperfusion injury, and autoimmune diseases. The aut…
New research explores how targeting the GPX4 protein could help treat cancer, autoimmune diseases, and nerve damage while overcoming deliver…
Medicinal plant extracts and phytochemicals show potential as multitargeted candidates for metastatic melanoma
Drug Pipeline Sys. Review
Medicinal plant extracts and phytochemicals show potential as multitargeted candidates for metastatic melanoma Plant extracts show promise for treating advanced melanoma skin cancer
This narrative review explores the potential of medicinal plant extracts and isolated phytochemicals as multitargeted therapeutic candidates…
Certain medicinal plants and their natural compounds may offer a new way to target multiple pathways in advanced melanoma.
Astragalus Polysaccharides and Astragaloside IV Modulate Immunity and Tumor Metabolism in Preclinical Cancer Models
Drug Pipeline Sys. Review
Astragalus Polysaccharides and Astragaloside IV Modulate Immunity and Tumor Metabolism in Preclinical Cancer Models Astragalus compounds may help the immune system fight cancer cells
This systematic review synthesizes preclinical evidence on Astragalus polysaccharides and Astragaloside IV in cancer. The authors report tha…
New research shows how specific compounds from the Astragalus plant could help the immune system recognize and attack cancer cells more effe…
Integrating Digital Health and Pharmacometric Modeling to Enhance Clinical Pharmacy in Africa
Drug Pipeline Sys. Review
Integrating Digital Health and Pharmacometric Modeling to Enhance Clinical Pharmacy in Africa Digital health and AI tools could improve pharmacy care in Africa
Digital health tools and AI-driven pharmacometrics offer significant potential to optimize medication management and precision medicine for …
New tools like mobile apps and AI could help pharmacists in Africa provide more personalized medicine and better drug management.
Astragaloside IV significantly reduces renal fibrosis markers and serum creatinine in preclinical animal models
Drug Pipeline Meta-analysis
Astragaloside IV significantly reduces renal fibrosis markers and serum creatinine in preclinical animal models Astragaloside IV Shows Potential for Treating Chronic Kidney Disease
This meta-analysis of preclinical animal studies indicates that Astragaloside IV significantly reduces serum creatinine, blood urea nitrogen…
Early research in animal models suggests that Astragaloside IV may reduce key markers of kidney damage and fibrosis in chronic kidney diseas…
Tripterygium glycosides provide renal protective effects in animal models of diabetic nephropathy
Drug Pipeline Meta-analysis
Tripterygium glycosides provide renal protective effects in animal models of diabetic nephropathy Tripterygium glycosides show potential to protect kidneys in diabetes
This meta-analysis of preclinical animal models indicates that tripterygium glycosides (TGs) significantly reduce markers of renal dysfuncti…
New research on animal models suggests tripterygium glycosides may protect kidneys from damage caused by diabetes, but specific dosing is cr…
Self-administered ivermectin and fenbendazole in a patient with metastatic melanoma showed mixed radiographic and ctDNA responses
Oncology Guideline
Self-administered ivermectin and fenbendazole in a patient with metastatic melanoma showed mixed radiographic and ctDNA responses One man with melanoma tries antiparasitic drugs for his cancer
This case report describes a 74-year-old man with metastatic melanoma who self-administered ivermectin and fenbendazole. The patient experie…
A man with advanced melanoma saw a temporary drop in cancer markers after taking ivermectin and fenbendazole, but the results were mixed.
MDT-guided perioperative strategy and staged anticoagulation manage pancreatic cancer in a patient with Moyamoya disease
Oncology Guideline
MDT-guided perioperative strategy and staged anticoagulation manage pancreatic cancer in a patient with Moyamoya disease Multidisciplinary Strategy Helps Manage Moyamoya Disease and Pancreatic Cancer
This case report describes a multidisciplinary team-guided perioperative strategy for a patient with Moyamoya disease and pancreatic ductal …
A specialized surgical strategy helped a patient with both Moyamoya disease and pancreatic cancer undergo surgery without any neurological c…
Nodal staging in upper eyelid Merkel cell carcinoma may influence disease-free status and survival outcomes
Oncology Guideline
Nodal staging in upper eyelid Merkel cell carcinoma may influence disease-free status and survival outcomes Eyelid cancer cases show importance of staging for survival
This case report describes 3 patients with upper eyelid Merkel cell carcinoma undergoing wide local excision and reconstruction. One patient…
A small study of eyelid cancer shows that skipping certain staging steps can lead to rapid spread and death.
Plant extracts like curcumin and resveratrol may inhibit HNSCC growth via specific signaling pathways
Drug Pipeline Sys. Review
Plant extracts like curcumin and resveratrol may inhibit HNSCC growth via specific signaling pathways Plant extracts may slow growth of head and neck cancer
This systematic review examines the effects of plant extracts, including resveratrol, curcumin, quercetin, and anthocyanins, on head and nec…
Certain plant compounds like curcumin and resveratrol show promise in stopping cancer cell growth and resisting chemotherapy in lab studies.
Seladelpar 10 mg shows optimal risk-benefit profile for UDCA-refractory primary biliary cholangitis patients
Drug Pipeline Meta-analysis
Seladelpar 10 mg shows optimal risk-benefit profile for UDCA-refractory primary biliary cholangitis patients New data identifies promising treatments for primary biliary cholangitis
This network meta-analysis of 1,540 patients evaluates various therapies for primary biliary cholangitis (PBC) with inadequate response to U…
New research identifies specific medications that may improve liver health and relieve itching for patients with primary biliary cholangitis…
Targeted Therapies May Shift COPD Care Toward Precision Medicine
Drug Pipeline Sys. Review
Targeted Therapies May Shift COPD Care Toward Precision Medicine Targeted Therapies Offer New Options for Chronic Obstructive Pulmonary Disease
This systematic review examines emerging targeted therapies for COPD, including monoclonal antibodies, small-molecule modulators, and stem c…
New targeted treatments like monoclonal antibodies may offer better options for people with COPD who do not respond well to standard inhaler…
Remimazolam may reduce early postoperative cognitive dysfunction risk and intraoperative opioid consumption in elderly patients
Drug Pipeline Meta-analysis
Remimazolam may reduce early postoperative cognitive dysfunction risk and intraoperative opioid consumption in elderly patients Remimazolam May Reduce Early Cognitive Risks After Surgery
This meta-analysis of 2,226 elderly surgical patients evaluated remimazolam compared to other sedatives. The analysis found that remimazolam…
A new sedative may help protect elderly patients from early cognitive issues after surgery while reducing the need for other pain medication…
Bangga extracts show antibacterial, anti-inflammatory, antiviral, and antitumor activity in preclinical synthesis
Drug Pipeline Sys. Review
Bangga extracts show antibacterial, anti-inflammatory, antiviral, and antitumor activity in preclinical synthesis Extracts of Aconitum tanguticum Show Potential for Several Conditions
This systematic review synthesizes preclinical evidence on Aconitum tanguticum (Bangga), reporting antibacterial, anti-inflammatory, antivir…
Research into Aconitum tanguticum extracts shows potential antibacterial, antiviral, and anti-inflammatory properties for various inflammato…
RPN1 overexpression promotes immune evasion and treatment resistance in multiple malignancies including hepatocellular carcinoma
Drug Pipeline Sys. Review
RPN1 overexpression promotes immune evasion and treatment resistance in multiple malignancies including hepatocellular carcinoma RPN1 Protein Linked to Worse Outcomes in Several Cancers
This systematic review examines the role of RPN1 in glioma, hepatocellular carcinoma, sarcoma, and triple-negative breast cancer. The author…
High levels of the RPN1 protein are linked to aggressive cancer features and help tumors hide from the body's immune system.
Pertuzumab-based regimens and FOLFIRINOX are cost-effective for specific cancers while neoadjuvant pembrolizumab is not
Drug Pipeline Meta-analysis
Pertuzumab-based regimens and FOLFIRINOX are cost-effective for specific cancers while neoadjuvant pembrolizumab is not New data shows cost-effectiveness of specific cancer drug regimens
This systematic review evaluates the cost-effectiveness of neoadjuvant regimens for breast, bladder, and pancreatic cancers. It finds pertuz…
New research identifies which cancer treatments are cost-effective, helping doctors and patients navigate the high costs of advanced care.
Polyherbal Unani Formulation Targets TGF-beta/Smad, NF-kappaB, and PI3K/Akt Pathways in Fibrosis and Cancer
Drug Pipeline Sys. Review
Polyherbal Unani Formulation Targets TGF-beta/Smad, NF-kappaB, and PI3K/Akt Pathways in Fibrosis and Cancer Polyherbal Unani Formulation shows potential to treat cancer and fibrosis
This systematic review examines the preclinical evidence for a polyherbal Unani formulation containing chebulinic acid, picrosides, flavonoi…
A traditional herbal blend may help fight the scarring and cell changes that make cancer and fibrosis diseases harder to treat.
Omeprazole, rabeprazole, pantoprazole, and lansoprazole are associated with increased fracture risk in elderly patients
Drug Pipeline Meta-analysis
Omeprazole, rabeprazole, pantoprazole, and lansoprazole are associated with increased fracture risk in elderly patients Some acid reflux medications may increase fracture risk in seniors
This network meta-analysis of 257,445 patients indicates that omeprazole, rabeprazole, pantoprazole, and lansoprazole are associated with in…
New data suggests that certain acid reflux medications may increase the risk of bone fractures for adults over age 65.
Botanical drug preparations and East Asian medicine show favorable signals for central precocious puberty
Drug Pipeline Sys. Review
Botanical drug preparations and East Asian medicine show favorable signals for central precocious puberty Botanical medicines show promise for children with early puberty
This systematic umbrella review evaluates botanical drug preparations and East Asian medicine interventions for children with CPP and ICPP. …
New research suggests that certain East Asian botanical medicines may help manage early puberty in children when combined with standard trea…
Oxidative stress and reactive oxygen species mediate retinal ganglion cell death and optic nerve damage
Drug Pipeline Sys. Review
Oxidative stress and reactive oxygen species mediate retinal ganglion cell death and optic nerve damage Oxidative stress and nerve damage drive glaucoma progression
This narrative review explores the role of oxidative stress and reactive oxygen species (ROS) as key mediators of retinal ganglion cell deat…
New research identifies how oxidative stress and reactive oxygen species damage the optic nerve in people with glaucoma.
Intraoperative dexmedetomidine use does not significantly impact overall survival or recurrence-free survival in cancer patients
Drug Pipeline Meta-analysis
Intraoperative dexmedetomidine use does not significantly impact overall survival or recurrence-free survival in cancer patients Review of dexmedetomidine use during surgery for patients with various types of cancer
This meta-analysis of real-world studies involving 4,613 cancer patients found no statistically significant association between intraoperati…
Doctors looked at how a specific medication used during surgery affects survival rates for cancer patients. The results were mixed.
ADC resistance in bladder cancer is multifactorial, review finds, with no validated overcoming strategy
Drug Pipeline Sys. Review
ADC resistance in bladder cancer is multifactorial, review finds, with no validated overcoming strategy New research identifies why some bladder cancer drugs stop working
This systematic review examines mechanisms of resistance to antibody-drug conjugates in locally advanced or metastatic urothelial carcinoma.…
Doctors are uncovering the complex reasons why certain bladder cancer treatments lose their power, helping pave the way for more precise the…
PCSK9 promotes tumorigenesis in preclinical models but shows inconsistent clinical prognostic value in breast cancer
Drug Pipeline Meta-analysis
PCSK9 promotes tumorigenesis in preclinical models but shows inconsistent clinical prognostic value in breast cancer Exploring the Role of PCSK9 Protein in Breast Cancer Growth and Spread
This systematic review examines the role of PCSK9 in breast cancer. Preclinical evidence consistently shows PCSK9 promotes tumorigenesis thr…
New research looks at how the PCSK9 protein affects breast cancer cells. Early tests show it may help tumors grow and spread more easily.
Herbal medicines and phytoconstituents modulate vagus nerve activity and cholinergic neurotransmission in animal models
Drug Pipeline Meta-analysis
Herbal medicines and phytoconstituents modulate vagus nerve activity and cholinergic neurotransmission in animal models Herbal Medicines May Influence Vagus Nerve Activity in Animal Models
This systematic review of 75 preclinical studies evaluates how herbal medicines, phytoconstituents, and essential oils influence vagus nerve…
Early research in animal models suggests that various herbal medicines and essential oils may influence vagus nerve activity and reduce infl…
AI and Machine Learning Reshape Drug-Induced Liver Injury Toxicogenomics
Drug Pipeline Sys. Review
AI and Machine Learning Reshape Drug-Induced Liver Injury Toxicogenomics Artificial intelligence helps predict liver damage from certain medications
AI and machine learning are moving DILI toxicogenomics from descriptive profiling toward mechanism-driven predictive toxicology.
New tools use artificial intelligence to identify the specific biological signals that cause liver injury from drugs.
Immune checkpoint inhibitors failed to demonstrate durable benefit in three large glioblastoma phase III trials
Drug Pipeline Sys. Review
Immune checkpoint inhibitors failed to demonstrate durable benefit in three large glioblastoma phase III trials Immune Checkpoint Inhibitors Show Limited Success for Glioblastoma Patients
This narrative review examines the current landscape of immune checkpoint inhibitors in glioblastoma management. The review notes that three…
Recent reviews of large clinical trials show that immune checkpoint inhibitors have not yet provided lasting benefits for patients with glio…
Dioscin shows therapeutic potential for various liver disorders including MASLD and hepatocellular carcinoma
Drug Pipeline Sys. Review
Dioscin shows therapeutic potential for various liver disorders including MASLD and hepatocellular carcinoma Plant Compound Dioscin Shows Promise For Liver Disease
This systematic review evaluates the hepatoprotective effects and pharmacokinetics of Dioscin in various liver diseases. The review conclude…
A plant compound called Dioscin may help protect the liver, but human evidence is still missing and high doses carry risks.
Hamburg Life After Cancer Program protocol aims to improve quality of life in cancer survivors
Oncology RCT
Hamburg Life After Cancer Program protocol aims to improve quality of life in cancer survivors New Program Aims to Improve Quality of Life for Cancer Survivors
This study protocol describes a single-arm intervention for 500 cancer survivors aged 18 to 65 years. The program includes patient navigatio…
A new multi-layered support program is being designed to help cancer survivors improve their quality of life through personalized care and p…
Rezvilutamide plus ADT with efavirenz-based ART yields PSA decline in one HIV-positive mHSPC patient
Oncology Guideline
Rezvilutamide plus ADT with efavirenz-based ART yields PSA decline in one HIV-positive mHSPC patient Rezvilutamide Shows Promise for Prostate Cancer in HIV Patients
This is a single-patient case report describing rezvilutamide plus androgen deprivation therapy in an HIV-positive patient with high-volume …
A single patient with both HIV and advanced prostate cancer showed significant improvement after starting a specific combination of treatmen…
Divide-Survive Matrix decouples proliferation from survival architecture in tumor assessment
Oncology Guideline
Divide-Survive Matrix decouples proliferation from survival architecture in tumor assessment New tool helps doctors assess tumor aggression and behavior
This guideline introduces the Divide-Survive (DvS) Matrix, a visual interpretive structure for multidisciplinary teams to assess tumor aggre…
A new visual framework helps medical teams separate a tumor's growth speed from its ability to survive and persist in the body.
PPSS shows rapid metastatic progression despite neoadjuvant Adriamycin, Ifosfamide, and Mesna
Oncology Guideline
PPSS shows rapid metastatic progression despite neoadjuvant Adriamycin, Ifosfamide, and Mesna Case Report Details Aggressive Synovial Sarcoma After Treatment
This case report describes a 60-year-old woman with primary pulmonary synovial sarcoma who received neoadjuvant Adriamycin, Ifosfamide, and …
A 60-year-old woman's synovial sarcoma shrank with chemo, but spread widely just four months after surgery.
Spatial immune-ecology framework proposed for gastric and GEJ adenocarcinoma ICI selection
Oncology Guideline
Spatial immune-ecology framework proposed for gastric and GEJ adenocarcinoma ICI selection Spatial Features Help Map Immune Responses in Stomach Cancer
This narrative guideline review proposes a spatial immune-ecology framework for advanced gastric and gastroesophageal junction adenocarcinom…
New research maps how the immune system interacts with stomach and esophageal cancer to help experts understand why some treatments work bet…
FDA-approved AI solutions for cancer histopathology are limited to a narrow range of applications
Oncology Guideline
FDA-approved AI solutions for cancer histopathology are limited to a narrow range of applications Only Four FDA Approved AI Solutions Exist for Cancer Histopathology
This guideline reviews the current state of AI in digital histopathology. It identifies only 4 FDA-approved solutions for a narrow range of …
While artificial intelligence is growing in cancer pathology, only four FDA-approved tools currently exist for specific clinical uses.
Gut-lung axis in lung cancer: soluble metabolites lead, neural pathways remain hypothetical
Oncology Sys. Review
Gut-lung axis in lung cancer: soluble metabolites lead, neural pathways remain hypothetical Gut Health Links May Influence Lung Cancer Treatment Paths
This narrative review with a systematic search examined 168 studies on the gut-lung axis in non-small-cell and small-cell lung cancer. Solub…
New research explores how the gut-lung axis and specific metabolites might play a role in managing lung cancer treatments.
Lipid metabolism reprogramming emerges as key mechanism of endocrine resistance in ER+ breast cancer
Oncology Sys. Review
Lipid metabolism reprogramming emerges as key mechanism of endocrine resistance in ER+ breast cancer Fat metabolism changes help breast cancer cells resist treatment
This systematic review synthesizes evidence that lipid metabolism reprogramming, including fatty acid synthesis, cholesterol metabolism, lip…
New research identifies how changes in fat metabolism allow certain breast cancer cells to survive and resist standard hormone therapies.
Macrophage pyroptosis drives intestinal inflammation and mucosal barrier impairment in inflammatory bowel disease
Genetics & Precision Medicine Sys. Review
Macrophage pyroptosis drives intestinal inflammation and mucosal barrier impairment in inflammatory bowel disease Cell death process drives inflammation in inflammatory bowel disease
This systematic review explores the role of macrophage pyroptosis in the pathological evolution of inflammatory bowel disease. The authors c…
A specific type of cell death called macrophage pyroptosis triggers the release of harmful signals that damage the gut lining in inflammator…
Sex and gender-tailored screening strategies aim to address disparities in colorectal cancer detection and participation
Oncology Guideline
Sex and gender-tailored screening strategies aim to address disparities in colorectal cancer detection and participation Experts identify ways to improve colorectal cancer screening for everyone
This consensus study identifies significant disparities in colorectal cancer incidence, age of onset, and screening participation between me…
Men and women face different barriers and risks when it comes to colorectal cancer, making tailored screening strategies vital for better he…
Splenic hilum nodal involvement is rare in pancreatic body adenocarcinoma with a 1.1% prevalence
Oncology Meta-analysis
Splenic hilum nodal involvement is rare in pancreatic body adenocarcinoma with a 1.1% prevalence Nodal Involvement Near the Spleen Linked to Pancreatic Cancer
This meta-analysis of 2260 patients evaluates the prevalence of splenic hilum and splenic artery nodal involvement in pancreatic ductal aden…
New data shows that while certain lymph nodes near the spleen are often involved in pancreatic cancer, they may not change survival outcomes…
Low inferior mesenteric artery ligation does not significantly impact survival in rectosigmoid cancer patients
Oncology Meta-analysis
Low inferior mesenteric artery ligation does not significantly impact survival in rectosigmoid cancer patients Surgery Technique Comparison Shows Similar Outcomes for Rectosigmoid Cancer
This meta-analysis of 1152 patients with rectosigmoid cancer compared low versus high inferior mesenteric artery ligation. The analysis foun…
A review of surgical techniques for rectosigmoid cancer shows that two different artery ligation methods result in similar survival rates.
Hypoxia-inducible factor 1 alpha promotes aggressive phenotypes and treatment resistance in cervical cancer
Oncology Sys. Review
Hypoxia-inducible factor 1 alpha promotes aggressive phenotypes and treatment resistance in cervical cancer HIF Factors Linked to Aggressive Cervical Cancer Growth
This narrative review explores the role of hypoxia-inducible factor (HIF) and HIF-1α in cervical cancer progression. The authors conclude th…
New research identifies how specific proteins called HIF and HIF-1α may drive tumor growth and treatment resistance in cervical cancer.
MRI-based radiomics models achieve 0.91 AUC for predicting GPC3 expression in hepatocellular carcinoma
Oncology Meta-analysis
MRI-based radiomics models achieve 0.91 AUC for predicting GPC3 expression in hepatocellular carcinoma MRI Radiomics Models Predict GPC3 Expression in Liver Cancer
This meta-analysis of 7 retrospective studies evaluated the diagnostic accuracy of MRI-based radiomics for predicting GPC3 expression in 1,2…
New MRI-based radiomics models show high accuracy in predicting GPC3 expression, offering a noninvasive way to identify patients for targete…
High Dietary Inflammatory Potential Correlates with Increased Risk of Oral Cancer
Oncology Meta-analysis
High Dietary Inflammatory Potential Correlates with Increased Risk of Oral Cancer High Dietary Inflammation Linked to Increased Risk of Oral Cancer
A meta-analysis reveals that high dietary inflammatory potential significantly increases oral cancer risk, highlighting the role of nutritio…
A high inflammatory diet may increase the risk of oral cancer, suggesting that changing your eating habits could help protect your oral heal…
FDA Approves Hyrnuo (zongertinib) for HER2 TKD Mutant Non-Squamous NSCLC After Prior Therapy
Oncology FDA Approval
FDA Approves Hyrnuo (zongertinib) for HER2 TKD Mutant Non-Squamous NSCLC After Prior Therapy FDA Approves New Targeted Drug for a Type of Lung Cancer
The FDA granted accelerated approval to Hyrnuo (zongertinib) for adults with locally advanced or metastatic non-squamous NSCLC harboring HER…
The FDA has approved Hyrnuo for adults with advanced non-small cell lung cancer that has a specific HER2 gene change. It is for patients who…
Gut microbiome composition correlates with clinical outcomes in hepatocellular carcinoma patients treated with immune checkpoint inhibitors
Oncology Meta-analysis
Gut microbiome composition correlates with clinical outcomes in hepatocellular carcinoma patients treated with immune checkpoint inhibitors Gut bacteria may influence how liver cancer patients respond to treatment
This meta-analysis of 13 papers examines the relationship between gut microbiota and clinical outcomes in patients with intermediate-to-adva…
Specific types of gut bacteria are linked to how well liver cancer patients respond to immune-based therapies.
Encorafenib and Binimetinib Combination Therapy for Patients with BRAF Mutated Cutaneous Melanoma
Oncology RCT
Encorafenib and Binimetinib Combination Therapy for Patients with BRAF Mutated Cutaneous Melanoma Trial Shows Encorafenib and Binimetinib for Melanoma Patients
This trial evaluates the safety and efficacy of encorafenib and binimetinib in patients with resected stage IIB/IIC melanoma.
A clinical trial shows that a combination of encorafenib and binimetinib may improve recurrence-free survival for patients with specific mel…
Alemtuzumab-based therapy achieves 81.9% response rate in adult T-cell prolymphocytic leukemia
Oncology Meta-analysis
Alemtuzumab-based therapy achieves 81.9% response rate in adult T-cell prolymphocytic leukemia Alemtuzumab Therapy Shows High Response Rates for T-cell Leukemia
This meta-analysis of 200 patients with T-cell prolymphocytic leukemia (T-PLL) found an 81.9% overall response rate to alemtuzumab-based the…
Alemtuzumab-based therapy shows an 81.9% response rate for adults with T-cell prolymphocytic leukemia, with some patients surviving long-ter…
Thoracic Radiotherapy Linked to 7.6% Pooled Incidence of Reported Atrial Fibrillation
Oncology Meta-analysis
Thoracic Radiotherapy Linked to 7.6% Pooled Incidence of Reported Atrial Fibrillation Thoracic radiation for cancer may increase risk of heart rhythm issues
This meta-analysis of 9 cohort-level estimates examines reported atrial fibrillation after thoracic radiotherapy in adults with thoracic mal…
New data shows that patients receiving radiation for chest cancers may face a higher risk of developing atrial fibrillation, a common heart …
HER2-low breast cancer shows distinct survival trajectories versus HER2-positive in systematic review
Oncology Meta-analysis
HER2-low breast cancer shows distinct survival trajectories versus HER2-positive in systematic review HER2-Low Status Shows Distinct Survival Paths in Breast Cancer
This systematic review of 10 trials synthesizes evidence on survival outcomes in HER2-low versus HER2-positive breast cancer. The authors re…
New analysis shows that HER2-low breast cancer tumors follow different survival paths than HER2-positive tumors, which may help doctors plan…